Elite Care, RX v. Premier Comp Solutions ( 2023 )


Menu:
  • J-E02002-22
    
    2023 PA Super 88
    ELITE CARE, RX, LLC                    :   IN THE SUPERIOR COURT OF
    :        PENNSYLVANIA
    :
    v.                        :
    :
    :
    PREMIER COMP SOLUTIONS, LLC;           :
    LAUNDRY OWNERS' MUTUAL                 :
    LIABILITY INSURANCE                    :   No. 1144 WDA 2020
    ASSOCIATION; UPMC BENEFIT              :
    MANAGEMENT SERVICES, INC.              :
    D/B/A UPMC WORK PARTNERS;              :
    LACKAWANNA CASUALTY COMPANY;           :
    AND BRICK STREET MUTUAL                :
    INSURANCE COMPANY                      :
    :
    :
    APPEAL OF: PREMIER COMP                :
    SOLUTIONS, LLC, LAUNDRY                :
    OWNERS' MUTUAL LIABILITY               :
    INSURANCE ASSOCIATION,                 :
    LACKAWANNA CASUALTY COMPANY            :
    AND BRICK STREET MUTUAL                :
    INSURANCE COMPANY                      :
    Appeal from the Order Entered June 5, 2020
    In the Court of Common Pleas of Allegheny County Civil Division at
    No(s): GD-19-005312
    BEFORE: PANELLA, P.J., OLSON, J., DUBOW, J., KUNSELMAN, J., NICHOLS,
    J., MURRAY, J., McLAUGHLIN, J., McCAFFERY, J., and SULLIVAN,
    J.
    DISSENTING OPINION BY OLSON, J.:                     FILED: MAY 23, 2023
    I respectfully dissent from the learned Majority’s determination in this
    matter.
    The exclusivity provision of the Workers’ Compensation Act (“WCA”)
    declares:
    J-E02002-22
    The liability of an employer under [the WCA] shall be
    exclusive and in place of any and all other liability to such
    employes, his legal representative, husband or wife, parents,
    dependents, next of kin or anyone otherwise entitled to
    damages in any action at law or otherwise on account of any
    injury or death as defined in section 301(c)(1) and (2) or
    occupational disease as defined in section 108.
    77 P.S. § 481(a).
    Under this section, the WCA “is a worker’s exclusive remedy against his
    employer for an injury sustained in the course and scope of employment.”
    Lewis v. Sch. Dist. Of Phila., 
    538 A.2d 862
    , 867 (Pa. 1988). In other words,
    “[t]he exclusivity provision of the [WCA] essentially ‘bars tort actions flowing
    from any work-related injury.’” American Road Lines v. W.C.A.B. (Royal),
    
    39 A.3d 603
    , 610 (Pa. Cmwlth. 2012), quoting Kline v. Arden H. Verner
    Co., 
    469 A.2d 158
    , 160 (Pa. 1983).
    Our Supreme Court has concluded that the exclusivity provision of the
    WCA offers co-extensive immunity to both employers and their insurance
    carriers.    Specifically, the Supreme Court declared, under the WCA, “[t]he
    employer's immunity from tort action extends to its workers' compensation
    insurance carrier, protecting the insurer to the full extent of the employer's
    protection.” Kuney v. PMA Ins. Co., 
    578 A.2d 1285
    , 1286 (Pa. 1990); see
    also 77 P.S. § 501(a)(1) (“[the WCA] insurer shall assume the employer's
    liability hereunder and shall be entitled to all of the employer's immunities and
    protection hereunder”).       Thus, “[a]n employer's liability for work-related
    injuries is governed solely by the [WCA], and the same is true of a
    compensation insurance carrier.” Kuney, 578 A.2d at 1286. Further, as our
    -2-
    J-E02002-22
    Supreme Court has held, “[t]he exclusivity provisions of the [WCA] prohibit a
    tort action against the insurance carrier for damages caused by the insurer's
    allegedly intentional mishandling of the injured employee's compensation
    claim.” Id. at 1288.
    In the case at bar, Elite Care, Rx, LLC (hereinafter “Plaintiff”), filed suit
    against Appellants, all of whom are workers’ compensation insurance carriers
    or the agents of such insurers. Plaintiff’s Complaint, 4/9/19, at ¶¶ 8-9. Within
    its complaint, Plaintiff averred that “certain employees whose employers were
    insured by [Appellants] were injured during the course and scope of their
    work.” Id. at ¶ 35. The employees were prescribed medications for their
    injuries and a pharmacy, named Patient Direct RX, filled these prescriptions.
    See id. at ¶¶ 11, 21, and 35. According to Plaintiff, “[a]fter Patient Direct RX
    fill[ed] the prescriptions of these patients, certain Providers then purchase[d]
    the claims arising from these prescriptions (i.e. the right to bill and collect
    from the carrier) from Patient Direct RX, paying fair market value for the
    same.” Id. at ¶ 14. Plaintiff is “the manager and billing agent” for these
    Providers. Id. at ¶ 16.
    As Plaintiff claimed, Appellants failed to pay for the prescription
    medications that “each insured’s injured employee has received.” Id. at ¶ 20.
    Further, Plaintiff claimed, Appellants “have alleged that they are not required
    to pay [for the prescription medications] because [Plaintiff is] . . . not a Health
    Care Provider as defined by the” WCA. Id. at ¶ 22. According to Plaintiff,
    -3-
    J-E02002-22
    Appellants “have denied payment for 110 different injured employees
    resulting in $548,035.28 of unpaid medical prescriptions.” Id. at ¶ 38.
    Moreover, in an attempt to resolve the claim, Appellants demanded that
    Plaintiff file an application for fee review under the WCA. Id. at ¶ 29. Plaintiff
    claims, however, that after it obtained favorable administrative decisions,
    Appellants requested hearings before the Bureau of Workers’ Compensation,
    and, in front of the hearing officer, Appellants “frivolously and in bad faith
    asserted that [the fee review] process [was] improper.” Id. at ¶ 37.
    Plaintiff’s complaint contains four counts: 1) a demand for declaratory
    relief; 2) fraud; 3) civil conspiracy; and 4) unjust enrichment. Specifically, in
    Count 1, Plaintiff requested that the trial court declare that it “is a valid agent
    of [the] Health Care Providers and [Appellants] must pay for these
    medications . . . , plus 10% per annum, per 77 P.S. § 717.1.”1              Id. at
    Declaratory Relief “Wherefore” Clause.
    ____________________________________________
    1   In relevant part, 77 P.S. § 717.1(a) provides:
    The employer and insurer shall promptly investigate each injury
    reported or known to the employer and shall proceed promptly to
    commence the payment of compensation due either pursuant to
    an agreement upon the compensation payable or a notice of
    compensation payable as provided in section 407 or pursuant to
    a notice of temporary compensation payable as set forth in
    subsection (d), on forms prescribed by the department and
    furnished by the insurer. The first installment of compensation
    shall be paid not later than the twenty-first day after the employer
    has notice or knowledge of the employe's disability. Interest shall
    accrue on all due and unpaid compensation at the rate of ten per
    centum per annum.
    -4-
    J-E02002-22
    In Count 2, Plaintiff claimed that Appellants fraudulently asserted that
    Plaintiff “was not an agent of [the Health Care] Providers, and thus payment
    did not need to be made for the prescriptions their injured employees
    received.” Id. at ¶ 45. Moreover, Plaintiff claimed that Appellants “furthered
    this fraud by claiming that [Plaintiff’s] exclusive remedy to resolve this issue
    was to file [an application for fee review, but then, after Plaintiff received a
    favorable administrative decision, Appellants] . . . argued that the fee review
    process” was inappropriate.         See id. at ¶¶ 47-49. For this alleged fraud,
    Plaintiff sought $548,035.28 in “unpaid medical prescriptions,” plus the
    additional costs it expended during the fee review process.        Id. at Fraud
    “Wherefore” Clause.
    Plaintiff’s civil conspiracy claim, at Count 3, reiterated the allegations
    that supported its fraud claim and, in its Wherefore Clause, Plaintiff again
    demanded that Appellants pay the $548,035.28 as “unpaid medical
    prescriptions,” plus the additional costs Plaintiff expended during the fee
    review process. See id. at Civil Conspiracy “Wherefore” Clause.
    Finally, in the unjust enrichment claim at Count 4, Plaintiff alleged that
    it provided “the necessary prescriptions to the insureds’ injured employees
    ____________________________________________
    77 P.S. § 717.1(a). Under this section of the WCA, “[i]f an insurer fails to pay
    the entire bill within 30 days of receipt of the required bills and medical
    reports, interest shall accrue on the due and unpaid balance at 10% per
    annum.” 34 Pa.Code § 127.210.
    -5-
    J-E02002-22
    without receiving payment for the same” and that Plaintiff “conferred a
    financial benefit upon” Appellants in the amount of $548,035.28. Id. at ¶ 59.
    As is evident from the above, Plaintiff’s claims all seek payment for
    treatment that was provided under the WCA or compensation for damages
    caused    by   Appellants’   alleged   intentional   mishandling   of    workers’
    compensation claims, both of which occurred while Appellants acted within
    their roles as workers’ compensation insurers under the WCA.            As stated
    above, the WCA establishes the exclusive forum for resolution of both
    payment disputes and alleged mismanagement of workers’ compensation
    claims. See, e.g., 77 P.S. § 531(1)(i) (“[t]he employer shall provide payment
    in accordance with this section for reasonable surgical and medical services,
    services rendered by physicians or other health care providers”); Kuney, 578
    A.2d at 1288 (“[t]he exclusivity provisions of the [WCA] prohibit a tort action
    against the insurance carrier for damages caused by the insurer's allegedly
    intentional mishandling of the injured employee's compensation claim”). As
    such, Plaintiff is bound by the exclusive remedies of the WCA and Appellants
    enjoy statutory immunity from Plaintiff’s current action before the court of
    common pleas. Therefore, I would vacate the trial court’s order and hold that
    Plaintiff’s civil action is barred by the WCA.
    The learned Majority holds otherwise. As the Majority notes, one of the
    main issues in this case is whether Plaintiff – the agent of a putative health
    care provider – may receive compensation for treatment that Patient Direct
    RX provided under the WCA. Further, the Majority cites to the Commonwealth
    -6-
    J-E02002-22
    Court’s    opinion   in   Armour     Pharmacy      v.   Bureau     of   Workers’
    Compensation Fee Review Hearing Office (Wegman’s Food Markets,
    Inc.), 
    206 A.3d 660
     (Pa. Cmwlth. 2019) (en banc) (hereinafter “Armour I”),
    where the Commonwealth Court held that, in a fee review proceeding under
    the WCA, the Hearing Office has jurisdiction to determine whether a putative
    provider serves or functions as an actual “provider” under the WCA.
    Nevertheless, the Majority holds:      that Armour I was incorrectly decided;
    that the scope of the fee review process is limited to the ”amount or timeliness
    of payment for medical treatment;” and, that the determination of whether
    an entity is a “provider” is beyond the scope of a fee review.          See, e.g.,
    Majority Opinion at **8-11. The Majority then reasons that, because the issue
    of whether Plaintiff is a “provider” is beyond the scope of the fee review
    process, Appellants do not enjoy immunity from Plaintiff’s claims. See id. at
    **10-12.
    Respectfully, I believe the Majority is incorrect. I express no opinion on
    whether Armour I was correctly or incorrectly decided. However, regardless
    of whether Armour I was correctly decided, the issue of whether Plaintiff is a
    provider entitled to relief under the WCA can always be decided, under the
    WCA, by a workers’ compensation judge.           Indeed, as the Commonwealth
    Court explained:
    [A c]laimant can file a petition to establish [the i]nsurer's
    liability to [a putative provider], such as a review petition or
    a penalty petition. . . . Claimants have an incentive to file a
    petition on behalf of a provider because when an insurer
    violates the [WCA] by failing to make proper payment to a
    -7-
    J-E02002-22
    medical provider, the penalty is payable to the claimant [as
    a statutory incentive]. The absence of a direct statutory
    remedy for providers does not mean that [an appellate court]
    may expand the scope of a fee review to create a remedy.
    The matter is one for the legislature, assuming there is a
    need for a provider to have another remedy.
    Selective Ins. Co. of Am. V. Bureau of Workers’ Comp. Fee Review
    Hearing Office (The Physical Therapy Institute), 
    86 A.3d 300
    , 305 n.9
    (Pa. Cmwlth. 2014) (citations omitted), overruled, in part, by Armour I; see
    also Armour I, 
    206 A.3d at 672
     (“Our holding does not limit the
    determination of the status of a ‘provider’ to a fee review proceeding.     In
    appropriate cases, this question may also be determined by a workers'
    compensation judge in the course of a claim or penalty petition proceeding”).2
    Further, and more to the point, even if the determination of whether an
    entity is a “provider” is beyond the scope of the fee review process, this
    holding would not diminish Appellants’ statutory immunity from Plaintiff’s tort
    action, where Plaintiff’s claims either seek payment for treatment that was
    provided under the WCA or compensation for damages caused by the insurer's
    alleged intentional mishandling of the workers’ compensation claim.         As
    ____________________________________________
    2 Having a workers’ compensation judge make the determination of who is a
    “provider” under the WCA makes eminent sense. Workers’ compensation
    judges are uniquely qualified to make such decisions due to their expertise in
    the area of workers’ compensation law. Under the Majority decision, the
    interpretating of the WCA and determinations that impact this highly
    specialized body of law would be made by judges on the courts of common
    pleas who are generally not experienced in this field. Hence, the reason for
    the WCA’s exclusivity provisions.
    -8-
    J-E02002-22
    explained above, the WCA provides the exclusive forum for resolving both
    types of disputes and, thus, Plaintiff’s current action is barred by the WCA.
    Therefore, I respectfully dissent.
    -9-
    

Document Info

Docket Number: 1144 WDA 2020

Judges: Olson, J.

Filed Date: 5/23/2023

Precedential Status: Precedential

Modified Date: 5/23/2023